Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma - Luciano J. Costa; Nizar J. Bahlis; Aurore Perrot; Ajay K. Nooka; Jin Lu; Charlotte Pawlyn; Roberto Mina; Gaston Caeiro; Alain Kentos; Vania Hungria; Donna Reece; Ting Niu; et al. (New England Journal of Medicine, 2026)